Related Experiment Videos
Mutations in immunoglobulin-producing mouse myeloma cells.
Summary
Mouse myeloma cell variants spontaneously lost myeloma protein secretion at a high rate. Mutagen treatment with ICR-191 increased this rate and produced altered heavy chains.
Area of Science:
- * Molecular biology
- * Cell biology
- * Genetics
Background:
- * Myeloma cells are used to study protein secretion.
- * Understanding protein synthesis defects is crucial for disease research.
Purpose of the Study:
- * To identify and characterize variants of mouse myeloma cells defective in myeloma protein secretion.
- * To investigate the spontaneous mutation rate of protein secretion defects.
- * To examine the effect of a chemical mutagen on the frequency and nature of these variants.
Main Methods:
- * Cloning of mouse myeloma cell lines in soft agar.
- * Antiserum overlay method for screening protein secretion variants.
- * Treatment with the acridine half mustard ICR-191 to induce mutations.
Main Results:
- * High spontaneous rate (10^-3) of variants losing heavy chain synthesis.
- * Concomitant loss of light chain production in these variants.
- * Increased variant incidence and altered heavy chain synthesis after ICR-191 treatment.
Conclusions:
- * Myeloma protein heavy and light chain synthesis are coordinately regulated.
- * Genetic instability contributes to high rates of secretion defects in myeloma cells.
- * Chemical mutagens can induce novel protein variants.